Lunai Bioworks
LNAI
20 hedge funds and large institutions have $1.38M invested in Lunai Bioworks in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 25 closing their positions.
0.04% less ownership
Funds ownership: 0.1% → 0.06% (-0.04%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
52% less funds holding
Funds holding: 42 → 20 (-22)
67% less capital invested
Capital invested by funds: $4.17M → $1.38M (-$2.79M)
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$91K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$60K |
| 5 |
Two Sigma Investments
New York
|
+$39.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$343K |
| 2 |
Jane Street
New York
|
-$258K |
| 3 |
Goldman Sachs
New York
|
-$109K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$89.7K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$66.1K |
LNAI Hedge Fund Activity: Q3 2025 in Review
20 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2025, worth a combined $1.38M — down 67% from $4.17M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of LNAI and 3 opened new positions — a net loss of 22 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $91K. The largest seller was BlackRock, cutting an estimated $343K.
- 20 institutional investors held Lunai Bioworks (LNAI) as of Q3 2025, down from 42 in Q2 2025.
- Funds reported $1.38M of Lunai Bioworks stock for Q3 2025, down 67% quarter-over-quarter.
- 3 funds opened new Lunai Bioworks positions in Q3 2025 and 25 closed out, a net change of -22 holders.
- The largest Lunai Bioworks buyer in Q3 2025 was Renaissance Technologies, an estimated $91K added.
- The largest Lunai Bioworks seller in Q3 2025 was BlackRock, an estimated $343K sold.
Based on aggregated 13F filings for Q3 2025.